Sign inGet started

Clarus Ventures III, LLC

Insider CIK 1664942 · GRTS · FTSV 10% owner · AVRO 10% owner · ETTX 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GRTS Gritstone Oncology, Inc. C Conversion deriv2018-10-022018-10-02668,896— $00SEC↗
GRTS Gritstone Oncology, Inc. C Conversion deriv2018-10-022018-10-021,565,216— $00SEC↗
GRTS Gritstone Oncology, Inc. C Conversion2018-10-022018-10-022,234,112— $02,567,445SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-026,702,213— $00SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-028,552,024— $00SEC↗
ETTX Entasis Therapeutics Holdi C Conversion deriv2018-09-282018-10-027,500,000— $00SEC↗
GRTS Gritstone Oncology, Inc. P Buy2018-09-282018-10-02333,333$15.00 $5.00M333,333SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-02361,829— $0361,829SEC↗
ETTX Entasis Therapeutics Holdi P Buy2018-09-282018-10-02453,395$15.00 $6.80M1,623,405SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-02412,583— $01,170,010SEC↗
ETTX Entasis Therapeutics Holdi C Conversion2018-09-282018-10-02323,341— $0685,170SEC↗
FTSV Forty Seven, Inc. C Conversion deriv2018-07-022018-07-02755,780— $00SEC↗
FTSV Forty Seven, Inc. C Conversion deriv2018-07-022018-07-02938,489— $00SEC↗
FTSV Forty Seven, Inc. C Conversion deriv2018-07-022018-07-021,922,682— $00SEC↗
FTSV Forty Seven, Inc. C Conversion2018-07-022018-07-021,922,682— $03,616,951SEC↗
FTSV Forty Seven, Inc. P Buy2018-07-022018-07-02200,000$16.00 $3.20M3,816,951SEC↗
FTSV Forty Seven, Inc. C Conversion2018-07-022018-07-02938,489— $0938,489SEC↗
FTSV Forty Seven, Inc. C Conversion2018-07-022018-07-02755,780— $01,694,269SEC↗
AVRO AVROBIO, Inc. C Conversion deriv2018-06-252018-06-259,435,150— $00SEC↗
AVRO AVROBIO, Inc. C Conversion deriv2018-06-252018-06-252,805,179— $00SEC↗
AVRO AVROBIO, Inc. C Conversion2018-06-252018-06-252,283,434— $02,283,434SEC↗
AVRO AVROBIO, Inc. C Conversion2018-06-252018-06-25678,891— $02,962,325SEC↗